FI900231A0 - Cyklohexanacetaminderivat. - Google Patents

Cyklohexanacetaminderivat.

Info

Publication number
FI900231A0
FI900231A0 FI900231A FI900231A FI900231A0 FI 900231 A0 FI900231 A0 FI 900231A0 FI 900231 A FI900231 A FI 900231A FI 900231 A FI900231 A FI 900231A FI 900231 A0 FI900231 A0 FI 900231A0
Authority
FI
Finland
Prior art keywords
lower alkyl
aryl
hydrogen
chem
cyclohexaneacetamides
Prior art date
Application number
FI900231A
Other languages
English (en)
Finnish (fi)
Inventor
Gary Lee Olson
Original Assignee
Hoffmann La Roche
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Hoffmann La Roche filed Critical Hoffmann La Roche
Publication of FI900231A0 publication Critical patent/FI900231A0/fi

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
    • C07D403/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
    • C07D403/10—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings linked by a carbon chain containing aromatic rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D207/00—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D207/02—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D207/18—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having one double bond between ring members or between a ring member and a non-ring member
    • C07D207/22—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having one double bond between ring members or between a ring member and a non-ring member with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D207/24—Oxygen or sulfur atoms
    • C07D207/26—2-Pyrrolidones
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
    • C07D403/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
    • C07D403/08—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings linked by a carbon chain containing alicyclic rings

Landscapes

  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Neurosurgery (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Hospice & Palliative Care (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Psychiatry (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Pyrrole Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Treatments For Attaching Organic Compounds To Fibrous Goods (AREA)
  • Packging For Living Organisms, Food Or Medicinal Products That Are Sensitive To Environmental Conditiond (AREA)
  • Plural Heterocyclic Compounds (AREA)
FI900231A 1989-01-17 1990-01-16 Cyklohexanacetaminderivat. FI900231A0 (fi)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US29772689A 1989-01-17 1989-01-17
US37764389A 1989-07-10 1989-07-10

Publications (1)

Publication Number Publication Date
FI900231A0 true FI900231A0 (fi) 1990-01-16

Family

ID=26970288

Family Applications (1)

Application Number Title Priority Date Filing Date
FI900231A FI900231A0 (fi) 1989-01-17 1990-01-16 Cyklohexanacetaminderivat.

Country Status (16)

Country Link
EP (1) EP0381959B1 (ja)
JP (1) JPH02229154A (ja)
KR (1) KR900011759A (ja)
AT (1) ATE122037T1 (ja)
AU (1) AU625157B2 (ja)
CA (1) CA2007732A1 (ja)
DE (1) DE69019007T2 (ja)
DK (1) DK0381959T3 (ja)
ES (1) ES2071685T3 (ja)
FI (1) FI900231A0 (ja)
HU (1) HUT53607A (ja)
IL (1) IL93051A0 (ja)
MC (1) MC2081A1 (ja)
NO (1) NO174386C (ja)
NZ (1) NZ232112A (ja)
PT (1) PT92874A (ja)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR100395779B1 (ko) * 2001-05-25 2003-08-21 한국화학연구원 임의적으로 베타-위치가 치환된 알파-아릴알킬기의 제거를통해 3급 아미드 화합물로부터 2급 아미드 화합물을제조하는 방법
CN102227217A (zh) 2008-10-16 2011-10-26 约翰斯.霍普金斯大学 改善认知功能的方法和组合物
EP2919788A4 (en) 2012-11-14 2016-05-25 Univ Johns Hopkins METHODS AND COMPOSITIONS FOR THE TREATMENT OF SCHIZOPHRENIA
DK2968220T3 (da) 2013-03-15 2021-06-14 Agenebio Inc Fremgangsmåder og sammensætninger til forbedring af kognitiv funktion
EP2968237A4 (en) 2013-03-15 2016-08-31 Univ Johns Hopkins METHOD AND COMPOSITIONS FOR IMPROVING COGNITIVE FUNCTION
BR112017025031B1 (pt) 2015-05-22 2023-03-21 Agenebio, Inc Composições farmacêuticas de liberação prolongada de levetiracetam

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IT1045043B (it) * 1975-08-13 1980-04-21 Isf Spa Derivati pirrolidinici
DE3336024A1 (de) * 1983-10-04 1985-04-18 Boehringer Ingelheim KG, 6507 Ingelheim 4-amino-l-benzyl-pyrrolidinone und ihre saeureadditionssalze, verfahren zu ihrer herstellung und arzneimittel
US4668687A (en) * 1984-07-23 1987-05-26 Bristol-Myers Company Psychogeriatric 1-(2-pyrimidinyl)piperazinyl derivatives of 1-pyrrolidin-2-ones
IT1190378B (it) * 1985-06-21 1988-02-16 Isf Spa Derivati pirrolidonici
IT1224168B (it) * 1986-08-01 1990-09-26 Finanziaria R F Spa Ora Finanz Derivati del pirrolidin-2-one ad attivita' nootropa

Also Published As

Publication number Publication date
HU900127D0 (en) 1990-03-28
JPH02229154A (ja) 1990-09-11
ATE122037T1 (de) 1995-05-15
AU625157B2 (en) 1992-07-02
DE69019007D1 (de) 1995-06-08
HUT53607A (en) 1990-11-28
DE69019007T2 (de) 1995-09-14
NO174386B (no) 1994-01-17
CA2007732A1 (en) 1990-07-17
NO900234D0 (no) 1990-01-16
PT92874A (pt) 1990-07-31
AU4798890A (en) 1990-07-26
IL93051A0 (en) 1990-11-05
KR900011759A (ko) 1990-08-02
DK0381959T3 (da) 1995-09-04
EP0381959B1 (en) 1995-05-03
MC2081A1 (fr) 1991-01-07
EP0381959A1 (en) 1990-08-16
NO174386C (no) 1994-04-27
ES2071685T3 (es) 1995-07-01
NZ232112A (en) 1992-07-28
NO900234L (no) 1990-07-18

Similar Documents

Publication Publication Date Title
ATE60761T1 (de) Chinazolinderivate, verfahren zu deren herstellung und diese enthaltende pharmazeutische zusammensetzungen.
PH25571A (en) Alpha'-alkyl-4-amino-3-quinolinemethanols, 1-(4-aralkylamino-3-quinolinyl) alaknones, their use as medicaments
DE69414554D1 (de) Heterocyclische verbindungen und ihre herstellung und verwendung
BE905109A (fr) Derives de distamycine et leur procede de fabrication.
ZA89389B (en) Use of 1,4-disubstituted-piperidinyl compounds in the manufacture of a medicament for the treatment of insomnia
NO900234D0 (no) Cykloheksan-acetamidderivater.
SG48250A1 (en) 4-substituted dihydropyrido (4,3-d) pyrimidines as analgesics and topical antiinflammatory agents forthe treatment of skin disorders
PT87005A (pt) Process for preparing n-phenethylaminoalkyl-benzamide anti-arrhythmic agents
ATE137759T1 (de) S'-adenosyl-methionin-decarboxylase-inhibitoren
PT85866A (en) Process for the preparation of therapeutic agents for the treatment of peptic ulcers containing 1,2,3,6-tetrahydro-3-methyl-1-(5-oxohexyl)-7-propyl-purine,6-dione and their derivatives
ES2171389T3 (es) Derivados anticonvulsivos de aminoacidos.
AU1146895A (en) Novel medicaments containing 3-benzoyl-3,7-diazabicyclo {3.3.1}nonane compounds
ATE111468T1 (de) Cephalosporinderivate, verfahren zu ihrer herstellung und antibakterielle mittel.
ATE81466T1 (de) Verwendung von 2-oxo-imidazolidin-derivaten zur prophylaxe und zur behandlung von herzinsuffizienz.
ATE81465T1 (de) Verwendung von 2-oxo-imidazolidin-derivaten zur behandlung von nierenkrankheiten.
IE42048L (en) Dienylphosphates and 1, 4-cycloadducts.

Legal Events

Date Code Title Description
FD Application lapsed
FD Application lapsed

Owner name: F. HOFFMANN - LA ROCHE AG